Abstract
The goal of this work consisted in study of the immunomodulating action of the cytostatic drug cyclophosphamide (CP) on the natural cytotoxic activity of rat and mice splenocytes. The cytotoxicity of effector cells (EC) with respect to monolayer cell lines of the Zajdela rat hepatoma and the HTC rat hepatoma and of the MH-22a mouse hepatoma was determined with the aid of morphometric analysis. CP at a dose of 100 mg/kg 48 h after administration to animals has been shown to produce an immunomodulating effect on cytotoxicity of splenocytes—a suppressive one with respect to cell-targets (CT) of Zajdela hepatoma and an immunopotentiating one with respect to CT of HTC and MH-22 hepatomas. Possible mechanisms of the CP immunopotentiating action are discussed.
Similar content being viewed by others
Abbreviations
- CP:
-
cyclophosphamide
- CT:
-
cell-targets
- BFBS:
-
bovine fetal blood serum
- EC:
-
effector cells
- NK cells:
-
natural killer cells
- PF:
-
paraformaldehyde
References
Ahlenstiel, G., Titerence, R.H., Koh, C., Edlich, B., Feld, J.J., Rotman, Y., Ghany, M.G., Hoofnagle, J.H., Liang, T.J., Heller, T., and Rehermann, B., Natural Killer Cells are Polarized Toward Cytotoxicity in Chronic Hepatitis C in an Interferon-α-Dependent Manner, Gastroenterology, 2010, vol. 138, pp. 325–335.
Arase, H., Arase, N., and Saito, T., Fas-Mediated Cytotoxicity by Freshly Isolated Natural Killer Cells, J. Exp. Med., 1995, vol. 181, pp. 1235–1238.
Ballas, Z.K., Lymphokine-Activated Killer (LAK) Cells, I. Differential Recovery of LAK, Natural Killer Cells, and Cytotoxic T Lymphocytes After a Sublethal Dose of Cyclophosphamide, J. Immunol., 1986, vol. 137, pp. 2380–2384.
Berd, D., Mastrangelo, M.J., Engstrom, P.F., Paul, A., and Maguire, H., Augmentation of the Human Immune Response by Cyclophosphamide, Cancer Res., 1982, vol. 42, pp. 4862–4866.
Brock, N., and Wilmanns, H., Action of a Cyclic Phosphamide Ester of Nitrogen Mustard on Experimental Tumours in Rats, Dtsch. Med. Wochenschr., 1958, vol. 83, pp. 453–458.
Brode, S., and Cooke, A., Immune-Potentiating Effects of the Chemotherapeutic Drug Cyclophosphamide, Crit. Rev. Immunol., 2008, vol. 28, pp. 109–126.
Evans-Stormse, R.B., and Cidlowski, J.A., Delineation of an Antiapoptotic Action of Glucocorticoids in Hepatoma Cells: The Role of Nuclear Factor-κB, Endocrinology, 2000, vol. 141, pp. 1854–1862.
Ferro, M., Bassi, A.M., Penco, S., Piana, S., Usiglio, D., and Nanni, G., Comparative Assessment of the Cytotoxic Effects of Different Xenobiotics in Three Hepatoma cell Lines, Arzneimittelforschung, 1992, vol. 42, pp. 1053–1057.
Ghiringhelli, F., Larmonier, N., Schmitt, E., Parcellier, A., Cathelin, D., Garrido, C., Chauffert, B., Solary, E., Bonnotte, B., and Martin, F., CD4+CD25+ Regulatory T Cells Suppress Tumor Immunity but Are Sensitive to Cyclophosphamide Which Allows Immunotherapy of Established Tumors to Be Curative, Eur. J. Immunol., 2004, vol. 34, pp. 336–344.
Hengst, J.C., Mokyr, M.B., and Dray, S., Cooperation between Cyclophosphamide Tumoricidal Activity and Host Antitumor Immunity in the Cure of Mice Bearing Large MOPC-315 Tumors, Cancer Res., 1981, vol. 41, pp. 2163–2167.
Jiang, S., Song, M.J., Shin, E.C., Lee, M.O., Kim, S.J., and Park, J.H., Apoptosis in Human Hepatoma Cell Lines by Chemotherapeutic Drugs via Fas-Dependent and Fas-Independent Pathways, Hepatology, 1999, vol. 29, pp. 101–110.
Kashii, Y., Giorda, R., Herberman, R.B., Whiteside, T.L., and Vujanovic, N.L., Constitutive Expression and Role of the TNF Family Ligands in Apoptotic Killing of Tumor Cells by Human NK Cells, J. Immunol., 1999, vol. 163, pp. 5358–5366.
Kayagaki, N, Yamaguchi, N, Nakayama, M, Takeda, K, Akiba, H, Tsutsui, H, Okamura, H, Nakanishi, K, Okumura, K, and Yagita, H., Expression and Function of TNF-Related Apoptosis-Inducing Ligand on Murine Activated NK Cells, J. Immunol., 1999, vol. 163, pp. 1906–1913.
Keller, R., Macrophage-mediated Natural Cytotoxicity against Various Target Cells in vitro. I. Macrophages from Diverse Anatomical Sites and Different Strains of Rats and Mice, Br. J. Cancer, 1978, vol. 37, pp. 732–741.
Kim, H.R., Park, H.J., Park, J.H., Kim, S.J., Kim, K., and Kim, J., Characteristics of the Killing Mechanism of Human Natural Killer Cells against Hepatocellular Carcinoma Cell Lines HepG2 and Hep3B, Cancer Immunol. Immunother., 2004, vol. 53, pp. 461–470.
León, C.J., Gomez, S.M., Morantes, S.J., Cordero, C.P., and Aristizabal, FA., Sensitivity Profile of a Panel of Cell Lines Designed for the Evaluation of in vitro Cytotoxicity, Biomedica, 2006, vol. 26, pp. 161–168.
Li, A.E., Ito, H., Rovira, I.I., Kim, K.S., Takeda, K., Yu, Z.Y., Ferrans, V.J., and Finkel, T., A Role for Reactive Oxygen Species in Endothelial Cell Anoikis, Circ. Res., 1999, vol. 85, pp. 304–310.
Lutsiak, M.E., Semnani, R.T, De Pascalis, R., Kashmiri, S.V., Schlom, J., and Sabzevari, H., Inhibition of CD4(+)25+ T Regulatory Cell Function Implicated in Enhanced Immune Response by Low-Dose Cyclophosphamide, Blood, 2005, vol. 105, pp. 2862–2868.
Maguire, H.C., and Ettore, V.L., Enhancement of Dinitrochlorobenzene (DNCB) Contact Sensitization by Cyclophosphamide in the Guinea Pig, J. Invest. Dermatol., 1967, vol. 48, pp. 39–43.
Maguire, H.C., Maibach, H.I., and Minisce, L.W., Inhibition of Guinea Pig Anaphylactic Sensitization with Cyclophosphoramide, J. Invest. Dermatol., 1961, vol. 36, pp. 235–236.
Mantovani, A., Luini, W., Peri, G., Vecchi, A., and Spreafico, F., Effect of Chemotherapeutic Agents on Natural Cell-mediated Cytotoxicity in Mice, J. Natl. Cancer Inst., 1978, vol. 61, pp. 1255–1261.
Meyn, R.E., Stephens, L.C., Hunter, N.R., and Milas, L., Apoptosis in Murine Tumors Treated with Chemotherapy Agents, Anticancer Drugs, 1995, vol. 6, pp. 443–450.
Meyn, R.E., Stephens, L.C., Hunter, N.R., and Milas, L., Induction of Apoptosis in Murine Tumors by Cyclophosphamide, Cancer Chemother. Pharmacol., 1994, vol. 33, pp. 410–414.
Mokyr, M.B., and Dray, S., Some Advantages of Curing Mice Bearing a Large Subcutaneous MOPC-315 Tumor with a Low Dose Rather Than a High Dose of Cyclophosphamide, Cancer Res., 1986, vol. 43, pp. 3112–3119.
Motoyoshi, Y., Kaminoda, K., Saitoh, O., Hamasaki, K., Nakao, K., Ishii, N., Nagayama, Y., and Eguchi, K., Different Mechanisms for Anti-tumor Effects of Low- and High-Dose Cyclophosphamide, Oncol. Rep., 2006, vol. 16, pp. 141–146.
Oshimi, Y, Oda, S, Honda, Y, Nagata, S, and Miyazaki, S., Involvement of Fas Ligand and Fas-Mediated Pathway in the Cytotoxicity of Human Natural Killer Cells, J. Immunol., 1996, vol. 157, pp. 2909–2915.
Pogodina, O.N. and Bulychev, A.G., Effect of Immunosuppressors Cyclophosphane and 5-Fluorouracil on Natural Cytotoxicity and Activity of Lysosomal Enzymes of Splenocytes in C3HA Mice, Tsitologiia, 2003, vol. 45, no. 1, pp. 74–80.
Polak, L., Geleick, H., and Turk, J.L., Reversal by Cyclophosphamide of Tolerance in Contact Sensitization, Tolerance induced by prior feeding with DNCB. Immunology., 1975, vol. 28, pp. 939–942.
Rees, R.C., Reynolds, C.W., and Herberman, R.B., Rat Natural Killer Cell Activity against Lymphoid and Nonlymphoid Tumor Cells and Normal rat cell Lines, Cancer Res., 1983, vol. 43, pp. 4248–4252.
Santos, G.W., Owens, A.H., and Sensenbrenner, L.L., Effects of Selected Cytotoxic Agents on Antibody Production in Man: A Prelimary Report, Ann. N.Y. Acad. Sci., 1964, vol. 114, pp. 404–423.
Sato, K, Hida, S, Takayanagi, H, Yokochi, T, Kayagaki, N, Takeda, K, Yagita, H, Okumura, K, Tanaka, N, Taniguchi, T, and Ogasawara, K., Antiviral Response by Natural Killer Cells through TRAIL Gene Induction by IFN-α/β, Eur. J. Immunol., 2001, vol. 31, pp. 3138–3146.
Schiavoni, G., Mattei, F., Di Pucchio, T., Santini, S.M., Bracci, L., Belardelli, F., and Proietti, E., Cyclophosphamide Induces type I Interferon and Augments the Number of CD44hi T Lymphocytes in Mice: Implications for Strategies of Chemoimmunotherapy of Cancer, Blood, 2000, vol. 95, pp. 2024–2030.
Scoltock, A.B., Heimlich, G., and Cidlowski, J.A., Glucocorticoids Inhibit the Apoptotic Actions of UV-C but not Fas Ligand in Hepatoma Cells: Direct Evidence for a Critical Role of Bcl-xL, Cell Death Differ., 2007, vol. 14, pp. 840–850.
Shin, E.C., Shin, W.C., Choi, Y., Kim, H., Park, J.H., and Kim, S.J., Effect of Interferon-Γ on the Susceptibility to Fas (CD95/APO-1)-Mediated Cell Death in Human Hepatoma Cells, Cancer Immunol. Immunother., 2001, vol. 50, pp. 23–30.
Sládek, N.E., Aldehyde Dehydrogenase-Mediated Cellular Relative Insensitivity to the Oxazaphosphorines, Curr. Pharm. Des., 1999, vol. 5, pp. 607–625.
Stegmann, K.A., Björkstrom, N.K., Veber, H., Ciesek, S., Riese, P., Wiegand, J., Hadem, J., Suneetha, P.V., Jaroszewicz, J., Wang, C., Schlaphoff, V., Fytili, P., Cornberg, M., Manns, M.P., Geffers, R., Pietschmann, T., Guzman, C.A., Ljunggren, H.G., and Wedemeyer, H., Interferon-alpha-Induced TRAIL on Natural Killer Cells Is Associated with Control of Hepatitis C Virus Infection, Gastroenterology, 2010, vol. 138, pp. 1885–1897.
Teryukova, N.P., Pogodina, O.N., Blinova, G.I., and Ivanov, V.A., The Morphometric Analysis of Cytotoxical Action of Rats and Mice Splenocytes against Confluent Monolayer Cell Lines of Hepatomas, Tsitologiia, 2009, vol. 51, no. 4, pp. 302–310.
Thomson, A.W., Mathie, I.H., and Sewell, H.F., Cyclophosphamide-Induced Eosinophilia in the Rat: Concomitant Changes in T-Cell Subsets, B Cells and Large Granular Lymphocytes Within Lymphoid Tissues, Immunology, 1987, vol. 60, pp. 383–388.
Tokarevich, N.K., Pogodina, O.N., Freydlin, I.S., Kuzina, V.A., Kramskaya, T.A., and Artemenko, N.K., The Comparative Characteristics of the Immunogenic and Immunomodulating Activity of Different Antigenic Preparations of the Causative Agent of Q Fever Coxiella burnetii, Tsitologiia, 1994, vol. 36, no. 11, pp. 1102–1112.
Turk, J.L., and Parker, D., Effect of Cyclophosphamide on Immunological Control Mechanisms, Immunol. Rev., 1982, vol. 65, pp. 99–113.
Turk, J.L., Enhancement of the Delayed-Type Hypersensitivity Reaction by Oxazaphosphorines, Methods Find. Exp. Clin. Pharmacol., 1987, vol. 9, pp. 605–610.
Turk, J.L., Parker, D., and Cameron, A.E., The Effect of Cyclophosphamide on Immunological Control Mechanisms, Int. J. Tissue React., 1984, vol. 6, pp. 205–211.
Van der Most, R.G., Currie, A.J., Cleaver, A.L., Salmons, J., Nowak, A.K., Mahendran, S., Larma, I., Prosser, A., Robinson, B.W.S., Smyth, M.J., Scalzo, A.A., Degli-Esposti, M.A., and Lake, R.A., Cyclophosphamide Chemotherapy Sensitizes Tumor Cells to TRAIL-Dependent CD8 T Cell-Mediated Immune Attack Resulting in Suppression of Tumor Growth, PLoS ONE, 2009b, vol. 4, p. e6982.
Van der Most, R.G., Currie, A.J., Mahendran, S., Prosser, A., Darabi, A., Robinson, B.W., Nowak, A.K., and Lake, R.A., Tumor Eradication after Cyclophosphamide Depends on Concurrent Depletion of Regulatory T Cells: a Role for Cycling TNFR2-Expressing Effector-Suppressor T Cells in Limiting Effective Chemotherapy, Cancer Immunol. Immunother., 2009a, vol. 58, pp. 1219–1228.
Vujanovic, N.L., Nagashima, S., Herberman, R.B., and Whiteside, T.L., Nonsecretory Apoptotic Killing by Human NK Cells, J. Immunol., 1996, vol. 157, pp. 1117–1126.
Yano, H., Fukuda, K., Haramaki, M., Momosaki, S., Ogasawara, S., Higaki, K., and Kojiro, M., Expression of Fas and Anti-Fas-Mediated Apoptosis in Human Hepatocellular Carcinoma Cell Lines, J. Hepatol., 1996, vol. 25, pp. 454–464.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Teryukova, N.P., Pogodina, O.N., Blinova, G.I. et al. Immunomodulating effect of cyclophosphamide on cytotoxic activity of rat and mouse splenocytes. Cell Tiss. Biol. 5, 586–594 (2011). https://doi.org/10.1134/S1990519X11060137
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1990519X11060137